Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Dec 26;24(5):1057–1062. doi: 10.1016/j.bbmt.2017.12.791

Table 4.

SP Category and Patient Ancestry* by Search Outcome, N = 830 Patients

SP Category by Patient Ancestry N Patients N (%) with Identified 8/8 URD Patient Ancestry p-value N Received Transplant N (%) Transplants with 8/8 URD Patient Ancestry p-value
Total: 830 499 (60%) 443 286 (65%)
Very Good 217 217 (100%) 137 135 (99%)
European 188 188 (100%) N/A 119 118 (99%) 0.235
Non-European 28 28 (100%) 17 16 (94%)
Good 104 104 (100%) 67 64 (96%)
European 86 86 (100%) N/A 55 53 (96%) 0.452
Non-European 18 18 (100%) 12 11 (92%)
Fair 178 136 (76%) 87 69 (79%)
European 119 97 (82%) 0.024 60 52 (87%) 0.018
Non-European 58 38 (66%) 26 16 (62%)
Poor 33 16 (48%) 17 10 (59%)
European 19 14 (74%) 0.001 12 10 (83%) 0.003
Non-European 14 2 (14%) 5 0 (0%)
Very Poor 153 18 (12%) 71 7 (10%)
European 89 15 (17%) 0.024 50 7 (14%) 0.180
Non-European 63 3 (5%) 20 0 (0%)
Futile 145 8 (6%) 64 1 (2%)
European 57 6 (11%) 0.058 30 1 (3%) 0.476
Non-European 87 2 (2%) 33 0 (0%)
*

4 patients had missing ancestry information and are included according to their Search Prognosis category result but could not be included in the sub-analysis of European versus non-European patients within each group.